Skip to main navigation Skip to search Skip to main content

Amendment for the National Lung Matrix Trial: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer

Project Details

Short titleAmendment for the National Lung Matrix Trial: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer
StatusFinished
Effective start/end date1/10/17 → 31/03/19

Funding

  • Cancer Research UK